Cargando…
Using doxycycline for prophylaxis of bacterial sexually transmitted infections: considerations for the European Union and European Economic Area
Autores principales: | Mårdh, Otilia, Plachouras, Diamantis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655202/ https://www.ncbi.nlm.nih.gov/pubmed/37971658 http://dx.doi.org/10.2807/1560-7917.ES.2023.28.46.2300621 |
Ejemplares similares
-
Candida auris: epidemiological situation, laboratory capacity and preparedness in European Union and European Economic Area countries, 2013 to 2017
por: Kohlenberg, Anke, et al.
Publicado: (2018) -
Candida auris: epidemiological situation, laboratory capacity and preparedness in the European Union and European Economic Area*, January 2018 to May 2019
por: Plachouras, Diamantis, et al.
Publicado: (2020) -
Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections
por: Grant, Juliana S, et al.
Publicado: (2020) -
Towards elimination of hepatitis B and C in European Union and European Economic Area countries: monitoring the World Health Organization’s global health sector strategy core indicators and scaling up key interventions
por: Duffell, Erika F, et al.
Publicado: (2017) -
Healthcare-associated pneumonia in acute care hospitals in European Union/European Economic Area countries: an analysis of data from a point prevalence survey, 2011 to 2012
por: Walter, Jan, et al.
Publicado: (2018)